As entering global markets becomes a business necessity, many life sciences companies based in Europe and Asia look at the U.S. market with some trepidation. Management of these companies must address fundamental questions concerning their prospective U.S. affiliates—where to locate their headquarters, and what legal corporate structure to select among those questions—all while navigating complex issues related to immigration law, tax regulations and regulatory agencies. Using a case study format, this panel of experts will provide a road map to a successful landing in the United States.



Objectives:

Identify the key legal and business decision points in transitioning to the U.S. market.

Explore common mistakes companies have made in expanding businesses into this critical market.

Provide an interactive forum for discussion for companies that are contemplating expansion into the United States.